EUVIMEDEUVIMED entdecken
Crossref

Antiemetic Efficacy of Esculetin via Dopaminergic, Serotonergic, and Muscarinic Pathway Modulation: Insights From In Vivo and In Silico Studies

Afiya Ajmee, Anike Chakrabarty iD, Chinmoy Kumar Saha, Raihan Chowdhury iD, Mst Muslima Munni iD, Sumaya Akter Bithi, Israt Jahan Oni, Rakib Hossen iD, Emon Mia iD, Mohammed Alfaifi iD, Md Sakib Al Hasan iD, Muhammad Torequl Islam

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Afiya Ajmee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh. Hauptthemen laut MEDLINE: Antiemetics, Umbelliferones, Vomiting, Dopamine. Die Arbeit nennt 59 Literaturangaben. Gefördert von: King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esculetin (ELN), a naturally occurring coumarin derivative, possesses a range of pharmacological activities, yet its antiemetic potential remains underexplored. This study assessed the efficacy of ELN against copper sulfate pentahydrate (CuSO 4 .5H 2 O)‐induced emesis through a combined in vivo and in silico approach. In a validated chick emesis model, 3‐day‐old chicks were orally administered CuSO₄·5H 2 O (50 mg/kg) to induce vomiting. Standard antiemetic agents domperidone (DOM‐6 mg/kg), ondansetron (OND‐5 mg/kg), and hyoscine (HYO‐21 mg/kg) served as reference drugs. ELN was tested at doses of 5, 10, and 20 mg/kg, both as monotherapy and in combination with standard drugs, to evaluate dose−response relationships and potential drug−drug interactions. ELN‐20 demonstrated the most pronounced efficacy among the individual doses, producing the longest latency, surpassing the standard treatments OND, DOM, and HYO. Furthermore, the combination therapies ELN‐10 + DOM‐6 and ELN‐10 + HYS‐21 showed marked improvements, suggesting a synergistic interaction that enhances the overall therapeutic effect. Molecular docking studies were performed to investigate ELN's binding affinity (BA) with key emetogenic receptors, including dopaminergic (D 2 , D 3 ), serotonergic (5‐HT 3 ), and muscarinic (M 1 –M 5 ) subtypes. Docking results demonstrated supportive, moderate binding across dopaminergic (D 2, D 3 ), serotonergic (5‐HT 3 ), and muscarinic (M 1 –M 5 ) receptors, which, together with in vivo efficacy and synergistic effects with standard antiemetics, suggest a multi‐receptor involvement rather than definitive receptor blockade. Given its efficacy and multi‐target profile, ELN shows promise as a novel candidate for emesis management, warranting further preclinical and clinical investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiemeticsUmbelliferonesVomitingDopamineReceptors, MuscarinicAnimalsChickensMolecular Docking SimulationSerotoninCopper SulfateComputer Simulation

Stichwörter der Autor:innen

Gallus domesticusantiemeticcopper sulfateesculetinmolecular dockingsynergy

Substanzen

AntiemeticsesculetinUmbelliferonesDopamineSerotoninCopper SulfateReceptors, Muscarinic

Autor:innen und Institutionen

  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
  • Department of Biotechnology, Faculty of Engineering and Science, University of Greenwich, Medway, Kent, UK.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
  • Alor Dishari Research Organization, Dhaka, Bangladesh.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Phytochemistry and Biodiversity Research Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh.

ORCID-Profile: Anike Chakrabarty, Raihan Chowdhury, Mst Muslima Munni, Rakib Hossen, Emon Mia, Mohammed Alfaifi, Md Sakib Al Hasan

Förderung

  • King Khalid University

Zitieren

APA

Ajmee, A., Chakrabarty, A., Saha, C. K., Chowdhury, R., Munni, M. M., Bithi, S. A., Oni, I. J., Hossen, R., Mia, E., Alfaifi, M., Al Hasan, M. S., & Islam, M. T. (2026). Antiemetic Efficacy of Esculetin via Dopaminergic, Serotonergic, and Muscarinic Pathway Modulation: Insights From In Vivo and In Silico Studies. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70706

Vancouver

Ajmee A, Chakrabarty A, Saha CK, Chowdhury R, Munni MM, Bithi SA, et al. Antiemetic Efficacy of Esculetin via Dopaminergic, Serotonergic, and Muscarinic Pathway Modulation: Insights From In Vivo and In Silico Studies. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70706

BibTeX
@article{Ajmee2026,
  author = {Ajmee, Afiya and Chakrabarty, Anike and Saha, Chinmoy Kumar and Chowdhury, Raihan and Munni, Mst Muslima and Bithi, Sumaya Akter and Oni, Israt Jahan and Hossen, Rakib and Mia, Emon and Alfaifi, Mohammed and Al Hasan, Md Sakib and Islam, Muhammad Torequl},
  title = {Antiemetic Efficacy of Esculetin via Dopaminergic, Serotonergic, and Muscarinic Pathway Modulation: Insights From In Vivo and In Silico Studies},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70706}
}
Kostenlos starten →